{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:36:42Z","timestamp":1773175002954,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.mjafi.2023.09.008","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T07:04:38Z","timestamp":1697526278000},"page":"S297-S300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["Case of COVID-19 infection-induced complement-mediated thrombotic microangiopathy"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-2989","authenticated-orcid":false,"given":"Atul Kumar","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mjafi.2023.09.008_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.mjafi.2023.09.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"issue":"2","key":"10.1016\/j.mjafi.2023.09.008_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/infdis\/jiaa646","article-title":"Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes","volume":"223","author":"de Nooijer","year":"2021","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.mjafi.2023.09.008_bib4","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.mjafi.2023.09.008_bib5","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00467-021-05390-4","article-title":"Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection","volume":"37","author":"Khandelwal","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1016\/j.mjafi.2023.09.008_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261113","article-title":"Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: retrospective cohort study","volume":"16","author":"Ruggenenti","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mjafi.2023.09.008_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40620-021-01125-8","article-title":"COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy","volume":"35","author":"Gill","year":"2022","journal-title":"J Nephrol"},{"issue":"6","key":"10.1016\/j.mjafi.2023.09.008_bib8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40620-020-00858-2","article-title":"Eculizumab treatment for renal failure in a pediatric patient with COVID-19","volume":"33","author":"Mahajan","year":"2020","journal-title":"J Nephrol"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123723001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123723001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T11:59:33Z","timestamp":1733054373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123723001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":8,"alternative-id":["S0377123723001600"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2023.09.008","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case of COVID-19 infection-induced complement-mediated thrombotic microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2023.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}